Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile. Issue 4 (14th March 2019) - Lukin, Dana J; Lawlor, Garrett; Hudesman, David P; Durbin, Laura; Axelrad, Jordan E; Passi, Monica; Cavaliere, Kimberly; Coburn, Elliot; Loftus, Michelle; Jen, Henry; Feathers, Alexandra; Rosen, Melissa H; et al.